Kidney Tumour SBRT (Renal SABR)
High-dose Stereotactic Body Radiotherapy for primary renal cell carcinoma and medically inoperable kidney tumors.
Non-invasive stereotactic radiation destroying kidney tumors without incisions or blood loss.
Historically considered radiation-resistant, primary renal cell carcinoma (RCC) has been shown to respond with high local control rates (exceeding 90%) when exposed to ablative doses delivered via Stereotactic Body Radiotherapy (SBRT/SABR).
Kidney SBRT is an ideal non-surgical treatment for patients who are elderly, have pre-existing cardiovascular risk factors, or have solitary kidneys where surgical nephrectomy would risk immediate dialysis dependence.
Delivered in 3 to 5 outpatient sessions with respiratory motion tracking, Renal SABR destroys malignant renal tissue while preserving surrounding functional nephrons, stomach, duodenum, and colon.
Key Clinical Considerations in Your Consultation
Every recommendation is customized according to staging scans, pathology markers, and patient priorities.
Clinical evaluation of renal mass size, anatomy, and proximity to bowel loops
Non-surgical treatment option for medically inoperable or surgically complex cases
Preservation of baseline renal function and glomerular filtration rate (GFR)
Painless outpatient treatment in 3 to 5 visits with zero surgical incision or bleeding
Respiratory gating and 4D-CT simulation for renal motion tracking
Second opinion review of contrast-enhanced triphasic CT and MRI scans
Discuss Kidney Tumour SBRT (Renal SABR)
Bring biopsy reports, recent PET/CT or MRI scans, and operative summaries for a comprehensive consultation.